Cathy N Lam
Examiner (ID: 12915)
Most Active Art Unit | 2811 |
Art Unit(s) | 4122, 2811 |
Total Applications | 430 |
Issued Applications | 305 |
Pending Applications | 0 |
Abandoned Applications | 125 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5278040
[patent_doc_number] => 20090130172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Modular Bioresorbable or Biomedical, Biologically Active Supramolecular Materials'
[patent_app_type] => utility
[patent_app_number] => 11/913470
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16905
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913470
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913470 | Modular bioresorbable or biomedical, biologically active supramolecular materials | May 2, 2006 | Issued |
Array
(
[id] => 5643367
[patent_doc_number] => 20060281822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Treatment and prevention of elevated homocysteine'
[patent_app_type] => utility
[patent_app_number] => 11/407715
[patent_app_country] => US
[patent_app_date] => 2006-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3192
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281822.pdf
[firstpage_image] =>[orig_patent_app_number] => 11407715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/407715 | Treatment and prevention of elevated homocysteine | Apr 19, 2006 | Abandoned |
Array
(
[id] => 5672128
[patent_doc_number] => 20060177482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Stent with coatings containing self-assembled monolayers'
[patent_app_type] => utility
[patent_app_number] => 11/400433
[patent_app_country] => US
[patent_app_date] => 2006-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5503
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177482.pdf
[firstpage_image] =>[orig_patent_app_number] => 11400433
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/400433 | Stent with coatings containing self-assembled monolayers | Apr 5, 2006 | Abandoned |
Array
(
[id] => 5411085
[patent_doc_number] => 20090124984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Medical Appliance and Process for Producing the Appliance'
[patent_app_type] => utility
[patent_app_number] => 11/886750
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4732
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124984.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886750 | Medical Appliance and Process for Producing the Appliance | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5682597
[patent_doc_number] => 20060198867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'COMPOSITIONS AND METHODS OF ADMINISTERING RAPAMYCIN ANALOGS USING MEDICAL DEVICES FOR LONG-TERM EFFICACY'
[patent_app_type] => utility
[patent_app_number] => 11/277215
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22569
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198867.pdf
[firstpage_image] =>[orig_patent_app_number] => 11277215
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/277215 | COMPOSITIONS AND METHODS OF ADMINISTERING RAPAMYCIN ANALOGS USING MEDICAL DEVICES FOR LONG-TERM EFFICACY | Mar 21, 2006 | Abandoned |
Array
(
[id] => 6321344
[patent_doc_number] => 20100113502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands'
[patent_app_type] => utility
[patent_app_number] => 11/909089
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63792
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909089
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909089 | Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands | Mar 16, 2006 | Abandoned |
Array
(
[id] => 5004567
[patent_doc_number] => 20070202135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Ionized compositions and methods of use therefore'
[patent_app_type] => utility
[patent_app_number] => 11/361524
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5883
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202135.pdf
[firstpage_image] =>[orig_patent_app_number] => 11361524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361524 | Ionized compositions and methods of use therefore | Feb 23, 2006 | Abandoned |
Array
(
[id] => 6249446
[patent_doc_number] => 20100137417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Glucagon Receptor Antagonists, Preparation and Therapeutic Uses'
[patent_app_type] => utility
[patent_app_number] => 11/815987
[patent_app_country] => US
[patent_app_date] => 2006-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50098
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137417.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815987 | Glucagon receptor antagonists, preparation and therapeutic uses | Feb 8, 2006 | Issued |
Array
(
[id] => 4927045
[patent_doc_number] => 20080166408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Oral Dosage Form Comprising Rosiglitazone'
[patent_app_type] => utility
[patent_app_number] => 11/815326
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4368
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20080166408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815326
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815326 | Oral Dosage Form Comprising Rosiglitazone | Feb 2, 2006 | Abandoned |
Array
(
[id] => 6595055
[patent_doc_number] => 20100048543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 11/815182
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41458
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815182 | PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY | Jan 26, 2006 | Abandoned |
Array
(
[id] => 5410803
[patent_doc_number] => 20090124702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Pharmaceutical Compositions of Metformin'
[patent_app_type] => utility
[patent_app_number] => 11/883031
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3479
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124702.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883031
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883031 | Pharmaceutical Compositions of Metformin | Jan 23, 2006 | Abandoned |
Array
(
[id] => 4832928
[patent_doc_number] => 20080131475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Methods of Use of Dual Ppar Agonist Compounds and Drug Delivery Devices Containing Such Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/814265
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10784
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131475.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814265
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814265 | Methods of Use of Dual Ppar Agonist Compounds and Drug Delivery Devices Containing Such Compounds | Jan 16, 2006 | Abandoned |
Array
(
[id] => 6637355
[patent_doc_number] => 20100035897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists'
[patent_app_type] => utility
[patent_app_number] => 11/794641
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11599
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035897.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794641
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794641 | Pyridine, pyrimidine and pyrazine derivatives as GPCR agonists | Dec 29, 2005 | Issued |
Array
(
[id] => 4867556
[patent_doc_number] => 20080146615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Pharmaceutical Compositions Comprising Amorphous Benzimidazole Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/722247
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4863
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146615.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722247
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722247 | Pharmaceutical Compositions Comprising Amorphous Benzimidazole Compounds | Dec 19, 2005 | Abandoned |
Array
(
[id] => 5747534
[patent_doc_number] => 20060110465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Compositions addressing inflammation and/or degenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/301553
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6688
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301553 | Compositions addressing inflammation and/or degenerative disorders | Dec 12, 2005 | Abandoned |
Array
(
[id] => 4745316
[patent_doc_number] => 20080089918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Viscoelastic Solutions Containing Sodium Hyaluronate And Hydroxypropyl Methyl Cellulose, Preparation And Uses'
[patent_app_type] => utility
[patent_app_number] => 11/791603
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3596
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791603 | Viscoelastic Solutions Containing Sodium Hyaluronate And Hydroxypropyl Methyl Cellulose, Preparation And Uses | Nov 27, 2005 | Abandoned |
Array
(
[id] => 7976653
[patent_doc_number] => 08071073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Compositions comprising azelastine and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/284109
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43328
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284109
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284109 | Compositions comprising azelastine and methods of use thereof | Nov 21, 2005 | Issued |
Array
(
[id] => 10882026
[patent_doc_number] => 08906403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Biomaterials carrying cyclodextrins having improved absorption properties and used for the progressive and delayed release of therapeutic molecules'
[patent_app_type] => utility
[patent_app_number] => 11/719386
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6319
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11719386
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719386 | Biomaterials carrying cyclodextrins having improved absorption properties and used for the progressive and delayed release of therapeutic molecules | Nov 14, 2005 | Issued |
Array
(
[id] => 6499516
[patent_doc_number] => 20100286211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS'
[patent_app_type] => utility
[patent_app_number] => 11/576635
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35207
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286211.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576635
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576635 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | Oct 5, 2005 | Abandoned |
Array
(
[id] => 4657205
[patent_doc_number] => 20080026066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Liquids Containing Suspended Glass Particles'
[patent_app_type] => utility
[patent_app_number] => 10/599928
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1402
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599928 | Liquids Containing Suspended Glass Particles | Apr 12, 2005 | Abandoned |